A resolution designating July 17, 2024, as "Glioblastoma Awareness Day".
Latest Action
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S4096; text: CR S4090)
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™Senate Resolution 735 designates July 17, 2024, as "Glioblastoma Awareness Day." The resolution was introduced and agreed to in the Senate by unanimous consent without amendment. The purpose of the resolution is to raise public awareness about glioblastoma, a form of brain cancer. The resolution does not include legislative provisions, funding, or regulatory changes.
This non-binding Senate resolution officially recognizes a day to promote awareness of glioblastoma, aiming to increase public knowledge and support for those affected by this disease.
- Designates July 17, 2024, as "Glioblastoma Awareness Day."
- Passed in the Senate by unanimous consent without amendments.
- Does not include any funding, regulatory changes, or enforcement mechanisms.
['Individuals diagnosed with glioblastoma and their families', 'Health advocacy organizations focused on brain cancer', 'Medical research communities interested in glioblastoma']
['No direct funding or resources are allocated to support glioblastoma research or patient care.', 'As a non-binding resolution, it does not create enforceable obligations or policy changes.', 'Limited impact beyond symbolic recognition and awareness raising.']
The resolution was introduced and passed in the Senate during the 118th Congress. It reflects a common legislative practice of designating awareness days to highlight specific health issues. The resolution was agreed to without opposition, indicating broad bipartisan support for raising awareness about glioblastoma.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Increased public and media attention on glioblastoma may lead to greater advocacy and potential future funding initiatives.', 'Health organizations might use the designated day to organize events, fundraising, or educational campaigns.']
As a non-binding Senate resolution without funding or regulatory impact, this bill primarily serves a symbolic purpose. Transparency considerations include clear communication that the resolution does not create new obligations or resources. Oversight is minimal given the lack of implementation requirements.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.